Andrew Nager

Andrew Nager is currently the Director of Systems Biology at Pfizer Oncology, leading a group of 17 scientists focused on drug candidate prioritization and target discovery. They earned a Ph.D. in Biology from the Massachusetts Institute of Technology and a Bachelor of Science from Vanderbilt University. Previously, Andrew held several positions at Pfizer, including Senior Principal Scientist and Associate Research Fellow, where they contributed to multiple therapeutic modalities and established a cancer immunology department. Additionally, they were a Postdoctoral Fellow at Stanford University School of Medicine and have a strong background in biophysics, cell biology, and project management.